Remy Sukhija, Chief Commercial Officer at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 56,700 shares at $273.54 ($15.5M) on 2022-12-23, disclosed to the SEC on 2022-12-28.
Open-market sale of $15.5M MDGL by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $266.04 | 593 | $158K | 1.0% |
| 2 | $266.04 | 593 | $158K | 1.0% |
| 3 | $267.47 | 1,107 | $296K | 1.9% |
| 4 | $267.47 | 1,107 | $296K | 1.9% |
| 5 | $268.50 | 1,913 | $514K | 3.3% |
| 6 | $268.50 | 1,913 |
| $514K |
| 3.3% |
| 7 | $269.61 | 1,476 | $398K | 2.6% |
| 8 | $269.61 | 1,476 | $398K | 2.6% |
| 9 | $270.56 | 2,069 | $560K | 3.6% |
| 10 | $270.56 | 2,069 | $560K | 3.6% |
| 11 | $271.54 | 2,084 | $566K | 3.6% |
| 12 | $271.54 | 2,084 | $566K | 3.6% |
| 13 | $272.68 | 5,534 | $1.5M | 9.7% |
| 14 | $272.68 | 5,534 | $1.5M | 9.7% |
| 15 | $273.54 | 2,471 | $676K | 4.4% |
| 16 | $273.54 | 2,471 | $676K | 4.4% |
| 17 | $274.56 | 3,019 | $829K | 5.3% |
| 18 | $274.56 | 3,019 | $829K | 5.3% |
| 19 | $275.70 | 811 | $224K | 1.4% |
| 20 | $275.70 | 811 | $224K | 1.4% |
| 21 | $276.67 | 700 | $194K | 1.2% |
| 22 | $277.83 | 700 | $194K | 1.3% |
| 23 | $279.15 | 3,003 | $838K | 5.4% |
| 24 | $279.15 | 3,003 | $838K | 5.4% |
| 25 | $279.96 | 2,620 | $733K | 4.7% |
| 26 | $279.96 | 2,620 | $733K | 4.7% |
| 27 | $280.92 | 1,000 | $281K | 1.8% |
| 28 | $282.13 | 400 | $113K | 0.7% |
| 29 | $283.43 | 400 | $113K | 0.7% |
| 30 | $284.65 | 100 | $28K | 0.2% |
| Total | $273.80 avg | 56,700 | $15.5M | 100% |